Review of Clinical Studies Targeting Inflammatory Pathways for Individuals With Autism

Area of Science:

• Neuroscience
• Immunology
• Developmental Psychology

Background:

• Autism spectrum disorder (ASD) is increasingly associated with immune dysfunction and abnormal immune responses.
• Evidence suggests a link between maternal infections during pregnancy and ASD incidence, alongside higher rates of immune-related disorders in individuals with ASD and their families.
• Neuroinflammation and atypical central nervous system immunity are implicated in ASD, potentially linking inflammatory responses to behavioral symptoms.

Purpose of the Study:

• To review current literature on interventions targeting inflammatory pathways in individuals with ASD.
• To evaluate the efficacy of these interventions in improving autism symptoms and adaptation.

Main Methods:

• Literature review of studies investigating anti-inflammatory interventions for ASD.
• Analysis of existing evidence on the impact of immune-targeted therapies on autism symptoms.

Main Results:

• Current literature on the efficacy of anti-inflammatory interventions for ASD is limited.
• Large-scale randomized controlled trials are necessary to establish robust evidence for these interventions.
• Immune-mediated mechanisms may play a role in specific ASD subsets, such as those with gastrointestinal issues or developmental regression.

Conclusions:

• The role of immune-mediated mechanisms in ASD may be specific to certain subgroups.
• Individuals with concurrent immunological disorders, developmental regression, or high irritability might benefit most from immune-targeted interventions.
• Further clinical trials focusing on these specific ASD subsets are warranted.